Key facts
- It has raised $3.2M; the latest was Seed Round ($3.2M) in Mar 2026.
- Notable investors include 999 Family Office.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Oberland Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for Oberland Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Oberland Biotech
Manufacturer of cultivated animal protein designed to provide sustainable and nutritious food options. The company utilizes cellular agriculture and biotechnological processes to cultivate animal cells directly, providing food manufacturers with genuine animal proteins that reduce greenhouse gas emissions and resource consumption while maintaining traditional taste and safety standards.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Zug, Switzerland
- Founded
- 2024
- Website
- oberlandbiotech.com/
- Ownership
- Privately Held (backing)
Oberland Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Oberland Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Oberland Biotech in its N-PORT filings yet. We sweep new filings monthly.